May 5th, 2014
Two Experts Look at a Failed HDL Trial
William Edward Boden, MD and Prediman K Shah, MD
William Boden and PK Shah discuss the CHI-SQUARE trial, which failed to show a benefit for an HDL mimetic.
May 5th, 2014
What Role Should Coca-Cola Play in Obesity Research?
Larry Husten, PHD
Larry Husten asks: “What role should Coca-Cola and other food and beverage companies play in funding and communicating research about nutrition and obesity?”
May 5th, 2014
FDA Comes Out Against Aspirin for Primary Prevention
Larry Husten, PHD
In the latest development in a long-simmering debate, the FDA has announced that aspirin should not be marketed for primary prevention for heart attack or stroke. The announcement follows the FDA’s rejection on Friday of Bayer Healthcare’s decade-old petition requesting approval of a primary prevention indication. [PDF of FDA rejection letter] Aspirin is still widely used for primary prevention. Many […]
May 2nd, 2014
A New Tool to Discuss Primary Prevention with a Statin with Patients: Life Expectancy Gain
Darrel P Francis, MD FRCP
Darrel Francis describes how you can use life expectancy gain as a way to communicate with patients the pros and cons of taking a statin.